Fatma Akça

Dr. Fatma Akça

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NDNur Dikmen
Nur Dikmen
EÖEvren Özçınar
Evren Özçınar
FAFatma Akça
Fatma Akça
EŞEMRE ŞEN
EMRE ŞEN
AKALİ FUAT KARAÇUHA
ALİ FUAT KARAÇUHA
LYLevent Yazicioglu
Levent Yazicioglu
Background: We aimed to investigate the two-year outcomes of covered endovascular reconstruction (CERAB) of the aortic bifurcation in patients with complex aortoiliac occlusive dis ease. Methods: This study was prospectively initiated, with data retrospectively collected from 40 patients categorized as TASC II B, C, and D based on computed tomography angiography (CTA) findings. All patients underwent the CERAB procedure. We assessed the procedural outcomes, including clinical and symptomatic improvements, as well as patency rates over a two-year follow-up period. Results: A total of 40 patients (33 males and 7 females) with aorto-occlusive disease were treated using the CERAB procedure and included in this observational study. The technical success rate was 100% across all procedures. At 36 months, the overall primary patency, assisted primary patency, and secondary patency rates were 85%, 90%, and 92.5%, respectively. Conclusions: The two-year results of this study suggest that CERAB offers patency rates comparable to those reported in other studies for complex aorto-occlusive bifurcation diseases. The procedure showed favorable patency rates, particularly for more advanced TASC II B, C, and D lesions.

Verified
Journal Article
Open access
PDF file
MSMehmet Cahit Sarıcaoğlu
Mehmet Cahit Sarıcaoğlu
AHAli Ihsan Hasde
Ali Ihsan Hasde
AKALİ FUAT KARAÇUHA
ALİ FUAT KARAÇUHA
AKAhmet Kayan
Ahmet Kayan
OBOnur Buyukcakır
Onur Buyukcakır
SESadik Eryilmaz
Sadik Eryilmaz
Background: Deep vein thrombosis (DVT) is an important component of venous thromboembolism and can lead to pulmonary embolism with high morbidity and mortality. Anticoagulant therapy alone (AC) and catheter-directed thrombolysis (CDT) are commonly used strategies for the management of DVT. Although CDT has been reported to be effective in reducing the risk of post-thrombotic syndrome (PTS), it remains unclear in which patient groups it should be preferred due to the risk of bleeding. Methods: This retrospective study included 175 patients diagnosed with DVT between 2015 and 2024 (98 AC, 77 CDT). Patients with a diagnosis of proximal DVT, aged ≥18 years, and with at least 30 days of follow-up data were included. The primary endpoint was 30-day mortality and secondary endpoints were the length of hospitalization, pulmonary embolism, and bleeding complications. Results: The CDT group was superior to AC in thrombus clearance rates, especially in iliac vein thrombosis (97.7% vs. 78%, p = 0.003). Clinical symptoms improved faster in the CDT group, but total hospitalization was longer. There were no significant differences in bleeding complications and mortality rates between the two groups. Conclusions: The optimal approach to DVT treatment should be based on the patient’s individual risk factors. Although CDT provides a higher thrombus clearance rate, especially in iliac vein thrombosis, it may not be suitable for all patients. Future large-scale studies will contribute to a better understanding of the long-term outcomes of interventional therapies.

1 April 2024 in Turkish Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
EÖEvren Özçınar
Evren Özçınar
LYLevent Yazıcıoğlu
Levent Yazıcıoğlu
NDNur Dikmen
Nur Dikmen
ODOguzhan Durmaz
Oguzhan Durmaz
AGAyşegül Güven
Ayşegül Güven
AAAltan Ada
Altan Ada
In this article, we present a newly designed cerebral perfusion technique during the in situ fenestration procedure with three covered stent placement in an endovascular total aortic arch repair of a 68-year-old male patient. This technique enables the endovascular repair of the ascending aorta and aortic arch pathologies with commonly available thoracic aorta stent grafts in a safer and more effective manner.

10 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EÖEvren Özçınar
Evren Özçınar
FAFatma Akça
Fatma Akça
MSMehmet Cahit Sarıcaoğlu
Mehmet Cahit Sarıcaoğlu
AHAli Ihsan Hasde
Ali Ihsan Hasde
NDNur Dikmen
Nur Dikmen
SESadik Eryilmaz
Sadik Eryilmaz
Background: Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair (TEVAR) to include arch lesions. In situ needle fenestration (ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and Methods: A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024. The median age of the patients was 51,33 years (±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 min (range: 126–302). Two patients experienced a minor hematoma at the access site. Mortality was observed in one patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia. No procedure-related endoleak was observed during the intervention; however, eight patients required reintervention in the descending aorta. Conclusions: ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.

13 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
EÖEvren Özçınar
Evren Özçınar
FAFatma Akça
Fatma Akça
MSMehmet Cahit Sarıcaoğlu
Mehmet Cahit Sarıcaoğlu
AHAli Ihsan Hasde
Ali Ihsan Hasde
NDNur Dikmen
Nur Dikmen
SESadik Eryilmaz
Sadik Eryilmaz
Background:Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair(TEVAR) to include arch lesions.In situ needle fenestration(ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and methods:A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024.The median age of the patients was 51,33 years(±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 minutes (range: 126–302).Two patient experienced a minor hematoma at the access site. Mortality was observed in 1 patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia.No procedure-related endoleak was observed during the intervention; however, 8 patients required reintervention in the descending aorta. Conclusion:ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.

23 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FAFatma Akça
Fatma Akça
BABekir Boğaçhan Akkaya
Bekir Boğaçhan Akkaya
MSMehmet Cahit Sarıcaoğlu
Mehmet Cahit Sarıcaoğlu
OBOnur Buyukcakir
Onur Buyukcakir
EÖEvren Özçınar
Evren Özçınar
LYLevent Yazicioglu
Levent Yazicioglu
Background: To evaluate the real-world safety and mid-term clinical performance of the Ankura™ AAA Stent Graft System in patients undergoing endovascular aneurysm repair (EVAR). Materials and Methods: This prospective, multicenter PMCF study analyzed 100 patients with abdominal aortic aneurysms (AAAs). Patients were monitored for a mean duration of 2.26 years. Primary endpoints included 30-day major adverse events and 24-month treatment success. Statistical evaluation of risk factors for reintervention was performed using univariate logistic regression. Results: The study cohort was predominantly male (97%), with a mean age of 72.01 years. Hypertension (90%) and smoking (89%) were the most prevalent comorbidities. Regarding the primary endpoints, the 30-day MAE rate was 2%. During the overall follow-up (mean 2.26 years), the primary patency rate was 97%, demonstrating high structural integrity and sustained patency. However, the overall freedom from reintervention rate was 74%, corresponding to a 26% reintervention requirement and a 27% incidence of endoleak. Reinterventions were almost exclusively driven by these post-procedural morphological complications; specifically, 26 of the 27 patients with endoleaks required a secondary procedure. No preoperative clinical or anatomical parameters were identified as significant independent predictors of reintervention in the univariate analysis (p > 0.05). The overall mortality rate was 12%, with 0% aneurysm-related mortality. Conclusions: Mid-term success and reintervention after EVAR with the Ankura™ system are primarily driven by postoperative morphological complications, such as endoleaks, rather than baseline patient risk profiles. These findings underscore the critical importance of rigorous, lifelong radiological surveillance regardless of preoperative anatomical challenges.